Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cytotoxicity and aerodynamical testing of spray dried meloxicam forms for inhalation

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: CHVATAL, Anita (University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Szgede, Hungary)
  • Co-author(s): Anita Chvatal: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
    Rami Alzhrani: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
    Rita Ambrus: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
    Piroska Szabóné-Révész: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, Szeged, Hungary
    Amit Tiwari: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
    Sai H. S. Boddu: College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, United States
  • Abstract:

    Backgrounds

    Meloxicam is a poorly water-soluble COX-2 enzyme inhibitor used in the treatment of rheumatoid arthritis following oral administration. The selective COX-2 enzyme inhibition of meloxicam makes it useful in the local treatment of cystic fibrosis and other lung inflammations via inhalation. For pulmonary drug delivery one of the most

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses